Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment

Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment

US Patent 8263344 · Granted Sep 11, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for inhibiting diazepam binding protein2025
Bacterial and cell compositions for the treatment of colorectal cancer and metho2025
Immune checkpoint inhibitor combinations2025
Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 an2024
Immunogenic sequences from a phage tail length tape measure protein, bacteria ex2024
Methods for weight reduction2024
Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 an2023
Microbiota composition, as a marker of responsiveness to chemotherapy, and use o2022
Immune checkpoint inhibitor combinations2021
Methods and pharmaceutical compositions for modulating autophagy in a subject in2021
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2021
Combination of oncolytic virus with immune checkpoint modulators2020